Healthcare

Beckman Coulter puts itself up for sale: Journal

RobertDaniel

TEL AVIV (MarketWatch) -- Beckman Coulter Inc.,
BEC, +2.91%
the Brea, Calif., provider of laboratory tests, systems and supplies, has put itself up for sale, people familiar with the matter told The Wall Street Journal. Beckman Coulter's market value as of Thursday's closing price, $57.09, was just under $4 billion. In a late-Thursday report the Journal said the people familiar with the matter said BEC could draw bids exceeding $5 billion. In after-hours trading Thursday, the stock leaped 14% to $65. A number of private-equity firms and corporate rivals have expressed interest in Beckman Coulter, the Journal reported. Goldman Sachs is running the sale effort, which started a few weeks ago, the Journal reported.

Intraday Data provided by SIX Financial Information and subject to terms of use.
Historical and current end-of-day data provided by SIX Financial Information. Intraday data
delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Dow Jones & Company, Inc.
All quotes are in local exchange time. Real time last sale data provided by NASDAQ. More
information on NASDAQ traded symbols and their current financial status. Intraday
data delayed 15 minutes for Nasdaq, and 20 minutes for other exchanges. S&P/Dow Jones Indices (SM)
from Dow Jones & Company, Inc. SEHK intraday data is provided by SIX Financial Information and is
at least 60-minutes delayed. All quotes are in local exchange time.